Compare Repligen Corporation Common Stock (RGEN) vs Direxion Daily TSLA Bull 2X Shares (TSLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Direxion Daily TSLA Bull 2X Shares — how do they compare? Repligen Corporation Common Stock trades at $178.85 (market cap $11.31B), while Direxion Daily TSLA Bull 2X Shares trades at $9.26 (market cap $3.77B). The key difference: Repligen Corporation Common Stock is far larger — about 3× Direxion Daily TSLA Bull 2X Shares's market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, Direxion Daily TSLA Bull 2X Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Direxion Daily TSLA Bull 2X Shares for 15 Days on average.
| RGEN | TSLL | |
|---|---|---|
Market Cap | $11.31B | $3.77B |
Volume | 1,216,919 | 58,292,886 |
Sector | Health | Leveraged / Inverse |
52-Week High | $194.57 | $23.03 |
52-Week Low | $102.87 | $6.74 |
Typical Hold Time | 0 Days | 15 Days |
Enterprise Value | $11.20B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
TSLL (Direxion Daily TSLA Bull 2X Shares ETF) trades at $10.00, down 1.48% on the day, with mixed technical signals showing a neutral overall outlook. The leveraged ETF tracks Tesla's daily performance, amplified by 2x, and benefits from recent Tesla momentum driven by Cybercab event anticipation. Key support and resistance cluster around $10-$11, with RSI indicators showing conflicting signals between short-term overbought conditions and neutral medium-term momentum.
As a leveraged ETF, TSLL carries inherent decay risks and is suitable only for short-term trading. The outlook depends entirely on Tesla's performance, with recent positive sentiment around Tesla's upcoming events providing potential upside. However, the leveraged structure makes it vulnerable to volatility decay, requiring careful risk management for investors considering exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Direxion Daily TSLA Bull 2X Shares
TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.
Read more on TSLL →
